August 3, 2022From Dr. Bredesen, News

Criticism of the Bredesen Protocol

Dr. Bredesen addresses the destructive criticism of his successful, clinically proven approach to treating early-stage dementia. Read More »

July 25, 2022From Dr. Bredesen, News

Milestones, and Miles of Stones

Dr. Bredesen outlines his 30-year research journey, which has led to his latest clinical trial’s publication in JAD, talking about the milestones met, despite naysayers occasionally throwing stones and questioning its validity. Read More »

July 25, 2022KetoFLEX 12/3 Kitchen, News, Nutrition

KetoFLEX 12/3 Kitchen: Spain on a Small Plate

KetoFLEX 12/3 Kitchen offers Spain on a small plate with tapas recipes for Marinated Olives, Shrimp Ceviche, Garlic-Sautéed Mushrooms, and Summer Sangria. Read More »

July 22, 2022Behavior Change, From Valerie Driscoll, Insider Strategies, News, Nutrition

Word Salad

In her blog, “Word Salad” Valerie Driscoll shares her past poor eating habits and the mindset shift to eat to heal ourselves with informed nutritional choices. Read More »

July 21, 2022From Ram Rao, Insider Strategies, News, Nutrition

Fermented Foods, Gut, and Cognition

Dr. Ram Rao discusses probiotic and fermented foods, that when consumed, increase microbiome diversity and decrease inflammatory proteins protecting neurological processes (brain health). Read More »

July 21, 2022From Julie Gregory, News

An Open Letter to Dr. Hellmuth

In her blog, “An Open Letter to Dr. Hellmuth,” Julie Gregory responds to one of the harshest critics of the Bredesen Protocol by reminding her of the patients’ perspective. Just as early AIDS activists pushed for new treatments and a new approach to treat their disease to find an effective treatment, Alzheimer’s patients are demanding similar changes. Read More »

July 18, 2022Interviews, News

Is Reversing Early-Stage Alzheimer’s Disease Possible? A New Study Finds It May Be

Georgia Public Broadcasting’s Ellen Eldridge spoke to Dr. Bredesen about the successful clinical trial that his co-authors and he recently published in JAD (the Journal of Alzheimer’s Disease). The study looked at participants’ individualized causes for developing dementia or mild cognitive impairment and treated them successfully, with 84% showing improvement. Read More »

July 6, 2022News, Press Releases

Precision Medicine Approach Reverses Early-Stage Dementia

Amid repeated failures of drug trials for Alzheimer’s disease, a small pilot study using a precision medicine approach has reported the first promising results, improving cognitive scores in over 80% of patients, as published in the Journal of Alzheimer’s Disease. Read More »